MedElevator
Войти в исследования Current topics in medicinal chemistry · 2026
Molecular Insights into the Neurogenic Potential of Alpha-lipoic Acid.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gupta Samriddhi, Kaushal Shruti, Bhargava Priyanshu, Ishida Yoshiyuki, Terao Keiji, Kaul Sunil C, Dhanjal Jaspreet Kaur, Wadhwa Renu
Аннотация
INTRODUCTION: Alpha-Lipoic Acid (ALA) is known for its antioxidant and antiinflammatory properties; however, its direct role in neurogenesis remains undefined. This study evaluated the neurogenic potential of the R-enantiomer (R-ALA) using transcriptomic profiling and in vitro validation.
METHODS: Transcriptome analysis of R-ALA-treated cells was performed to identify differentially expressed genes and enriched pathways. Validation was conducted in different cell lines (C6, PC12, TGW) to assess neurite morphology and neuronal marker expression.
RESULTS: R-ALA induced strong upregulation of several neurogenesis-associated biomarkers and enriched pathways related to neurogenesis, axonogenesis, dendritogenesis, gliogenesis, and neurotransmission (serotonergic, GABAergic). In line with transcriptomic predictions, treated cells exhibited neurite outgrowth and increased expression of neuronal markers, including MAP2, β- tubulin III, NF-200, and GAP43.
DISCUSSION: The upregulation of neuron-specific markers and downregulation of progenitorassociated CD44 suggest a comprehensive activation of neuroplastic and regenerative processes, reinforcing ALA's potential as a neurogenic agent.
CONCLUSION: These findings provide the first integrated transcriptome-to-phenotype evidence that R-ALA promotes neurogenesis and neuronal differentiation in vitro, offering a basis for further in vivo exploration in neurodegenerative disorders.
METHODS: Transcriptome analysis of R-ALA-treated cells was performed to identify differentially expressed genes and enriched pathways. Validation was conducted in different cell lines (C6, PC12, TGW) to assess neurite morphology and neuronal marker expression.
RESULTS: R-ALA induced strong upregulation of several neurogenesis-associated biomarkers and enriched pathways related to neurogenesis, axonogenesis, dendritogenesis, gliogenesis, and neurotransmission (serotonergic, GABAergic). In line with transcriptomic predictions, treated cells exhibited neurite outgrowth and increased expression of neuronal markers, including MAP2, β- tubulin III, NF-200, and GAP43.
DISCUSSION: The upregulation of neuron-specific markers and downregulation of progenitorassociated CD44 suggest a comprehensive activation of neuroplastic and regenerative processes, reinforcing ALA's potential as a neurogenic agent.
CONCLUSION: These findings provide the first integrated transcriptome-to-phenotype evidence that R-ALA promotes neurogenesis and neuronal differentiation in vitro, offering a basis for further in vivo exploration in neurodegenerative disorders.